Correlation Engine 2.0
Clear Search sequence regions


  • anion (1)
  • metal (5)
  • naproxen (6)
  • oxygen (3)
  • peroxides (2)
  • Sizes of these terms reflect their relevance to your search.

    BiFeO3 (BFO) nanocage prepared by metal-organic-framework derivatization (MOF-d) was adopted as activator to first investigate the effect mechanism of visible-light on naproxen-degradation via peroxymonosulfate (PMS) activation. MOF-d BFO expressed more excellent PMS activation ability than hydrothermal-synthetic BFO, due to highly ordered mesopores. A 3.0 times higher pseudo-first-order degradation rate constant was achieved after visible-light introduced. The quenching experiments indicated that the contribution of ROS in naproxen degradation followed the order of SO4•->1O2 ≈ •OH in MOF-d BFO/PMS/dark system, while changed into h+>1O2 > >O2•-≈SO4•-> •OH after visible-light introduced. EPR tests first revealed that visible-light promoted 1O2 yield (non-radical pathway) but suppressed •OH and SO4•- generation (free-radical pathways). N2-purging experiments further proved that 1O2 primarily originates from the reaction between h+ and PMS, equivalently to that between O2 and e--h+ in MOF-d BFO/PMS/vis system. Under visible-light, PMS activation via Fe (III) might be hindered by e- filling on Fe 3d orbital and anion PMS preferred to approach h+ rather than e-, resulting in the decrease of •OH and SO4•- yields. Moreover, PMS faces competition from adsorbed-O2 and oxygen-vacancies for e- capture. The degradation-pathways for naproxen in dark and under visible light were both proposed in MOF-d BFO/PMS system. Copyright © 2022 Elsevier B.V. All rights reserved.

    Citation

    Juanjuan Yao, Zihan Chen, Huiying Zhang, Naiyun Gao, Zhi Zhang, Wenchao Jiang. New insight into the regulation mechanism of visible light in naproxen degradation via activation of peroxymonosulfate by MOF derived BiFeO3. Journal of hazardous materials. 2022 Jun 05;431:128513

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35219060

    View Full Text